Phase I trial investigating the safety and immunogenicity of Medicago's rabies vaccine.

Trial Profile

Phase I trial investigating the safety and immunogenicity of Medicago's rabies vaccine.

Planning
Phase of Trial: Phase I

Latest Information Update: 20 Jan 2012

At a glance

  • Drugs Rabies vaccine (Primary)
  • Indications Rabies
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Jan 2012 Medicago expects to initiate Good Manufacturing Practice (GMP) process development and a Good Laboratory Practice (GLP) toxicology study in 2012; following this, the company will initiate this phase I clinical trial.
    • 20 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top